Metabolic imaging of ischemic stroke: the present and future

Area of Science:

• Neurology
• Medical Imaging
• Biochemistry

Background:

• Cerebral metabolism assessment is crucial for guiding reperfusion therapies.
• Current clinical methods lack direct measures of metabolic activity.
• Surrogate markers are needed for patient selection and trial endpoints.

Purpose of the Study:

• To review existing imaging modalities as surrogate markers of cerebral metabolic activity.
• To discuss emerging metabolic imaging techniques in development.

Main Methods:

• Review of current clinical imaging techniques (e.g., MRI, CT, PET).
• Analysis of how these modalities indirectly reflect metabolic status.
• Survey of novel metabolic imaging technologies.

Main Results:

• Existing imaging modalities can serve as indirect indicators of metabolic function.
• Several promising new techniques are nearing clinical availability.
• These advancements aim to provide more direct metabolic data.

Conclusions:

• Current imaging techniques offer valuable surrogate markers for cerebral metabolism.
• Future metabolic imaging will enhance patient selection and clinical trial design.
• Advancements in metabolic imaging promise improved neurological patient care.